Recent News

Updates Surrounding Groundwater Contamination Litigation

In 2018, 3M Company agreed to settle decades-long litigation surrounding the contamination of the groundwater in the east metro of Minnesota. Here, the environmental litigation attorneys at The Law Offices of Peter Angelos P.C. detail recent updates to ongoing groundwater contamination litigation as well as the environmental repercussions of unethical and unsustainable practices by large…

Read More...

An Overview of the FDA Death Database Malfunction

Researchers have reported that the miscategorization of a slew of patient deaths by the FDA points to the potential unreliability of their adverse events database. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss how current protocols for reporting patient death through the FDA’s Manufacturer and User Facility Device Experience (MAUDE)…

Read More...

More Manufacturers Pull Generic Zantac Over Carcinogen Concerns

Manufacturers such as GlaxoSmithKline are pulling generic forms of Zantac off of the market, after Novartis’ Sandoz Inc. issued a voluntary recall earlier this week due to confirmed carcinogen contamination.  Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the updates to the ongoing Zantac claims. GlaxoSmithKline has stopped global distribution…

Read More...

Zantac Manufacturer Recalls Medication Due to Confirmed Contamination

Sandoz Inc. has voluntarily recalled the generic version of common medication Zantac after the medication was confirmed to be contaminated with a human carcinogen. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the updates to the ongoing Zantac claims.  Global health regulators recently raised concerns about the possibility that the…

Read More...

Carcinogen Found in Stomach Drug Leads to Halt in Distribution

Global health regulators have raised the alarm about the possibility that the widely used drug, Zantac, could be tainted with the same cancer-causing agent found in Valsartan earlier this year. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos detail the preliminary results of the FDA and EU probes. Officials are Investigating…

Read More...

White House to Ban Flavored E-Cigarettes

The Trump Administration has asked that the Food and Drug Administration (FDA) ban nontobacco e-cigarette flavors as a response to increased reports of serious respiratory illness linked to vaping. Here, the consumer product liability attorneys at The Law Offices of Peter Angelos discuss this breaking news.   Potential Vaping-Related Lung Illnesses Cause Nationwide Concern As…

Read More...

An Increase in Reported Vaping-Related Illnesses Leads to Investigation into the Safety of Vaping Devices

Due to an increase in reports of vaping-related illnesses in Maryland, the Maryland Department of Health is investigating five cases of severe lung illness in individuals who experienced respiratory symptoms after vaping in the last two months. Here, the attorneys at The Law Offices of Peter Angelos discuss the growing investigation regarding vaping-related illness and what this recent…

Read More...

Two Maryland Families Allege Weed Killer Causes Cancer

As the controversy surrounding Roundup weedkiller increases, more and more individuals and families are making cases against the manufacturer of the popular herbicide, Bayer AG. Recently, two Maryland families joined the significant amount of individuals suing Bayer on the grounds that Roundup causes cancer, and one of these cases is being litigated by attorney Jay…

Read More...

The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants

In response to the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) linked to Allergan BIOCELL textured breast implants, the Food and Drug Administration (FDA) has requested that Allergan voluntarily recall select breast implants and tissue expanders. As a result of the request for recall, Allergan has agreed to take its products associated with…

Read More...

FDA Issues Black Box Warning for Xeljanz and Xeljanz XR

In July 2019, the Food and Drug Administration (FDA) placed a Black Box Warning, the highest possible warning the FDA can mandate, on Pfizer’s blockbuster immunology drugs Xeljanz and Xeljanz XR. These new warnings will alert patients of risks including an increased risk of blood clots—and potentially, death. Here, the Baltimore pharmaceutical liability attorneys at…

Read More...